I

ITF Therapeutics

Develops and commercializes rare-disease therapies

Medical Science Liaison

Implementation & Technical Account ManagementConfirmed live in the last 24 hours
Full-timeKansas City, KS, USAIn-person

About the Job

Requirements

  • A degree in life science or a related field is required.
  • At least 3–5 years of related experience is required.
  • Ability to interpret and communicate complex scientific data to healthcare professionals is required.
  • A valid driver's license, personal automobile, and active vehicle insurance policy in good standing are required.
  • Must comply with facility-specific vendor credentialing requirements for routine entry to hospitals and other medical facilities, including training, background and drug checks, and proof of immunizations.
  • The role requires daily travel to and from customer accounts by driving and/or flying long distances, with overnight and weekend travel up to 75%; travel outside the assigned territory is also required as needed to support the team.

Responsibilities

  • Build and maintain strong, trust-based relationships with pediatric neurologists, neuromuscular specialists, and other key medical experts at major care centers.
  • Engage in scientific exchange with healthcare professionals about clinical and research data, and capture field insights to inform strategic plans.
  • Deliver fair-balanced, objective clinical and scientific presentations to healthcare professionals, payors, and patient organizations in response to unsolicited requests for information about company products.
  • Serve as a core liaison to key institutions, supporting ongoing and future clinical studies and scientific collaborations.
  • Attend national and regional medical meetings and symposia to engage in discussion and cultivate professional relationships.
  • Collaborate with external medical experts on medical affairs initiatives, including publications, medical education opportunities, and training as appropriate.
  • Assist in preparing and executing scientific materials for marketed and pipeline assets, including delivering presentations, assisting with slide preparation and review, and facilitating interactive discussion groups.

Desired Qualifications

  • An advanced scientific degree is preferred, including PhD, PharmD, MD, DNP, MSN, MS, or Genetic Counselor.
  • Preferably 8–10 years of related and progressive experience in pharmaceutical or biotech companies, clinical, and/or academic settings, including 3–5 years in the field and/or Medical Affairs.
  • Experience supporting Duchenne muscular dystrophy, neuromuscular disorders, genetics, rare and/or orphan products is preferred.
  • Experience supporting rare or ultra-rare disease therapeutics across clinical development and commercial stages is highly desirable.
  • Ability to translate complex and/or challenging scientific data into effective trainings, presentations, and face-to-face exchanges with medical, scientific, key opinion leader, and stakeholder audiences is preferred.
  • Experience in a small, rapidly growing biotech or start-up environment with a solutions-oriented approach is preferred.
  • Hands-on experience building strategic, long-term partnerships and developing tailored engagement plans aligned with business and medical objectives is preferred.
  • Skill in delivering high-impact presentations to internal and external stakeholders is preferred.
  • Ability to work independently in a field-based role while collaborating effectively within a Medical Affairs team is preferred.
  • Planning, organization, and time management skills are preferred.
  • Ability to support and prioritize multiple projects, including working on and leading projects and/or initiatives aligned to US Medical strategy, objectives, and tactics, is preferred.

About the Company

ITF Therapeutics

Develops and commercializes rare-disease therapies

ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Concord, NH
Founded
2024

Recently Posted Jobs

Explore more opportunities at ITF Therapeutics

See more jobs